scholarly journals Studies on the enzyme immunoassay of bio-active constituents contained in oriental medicinal drugs. III. Enzyme immunoassay of paeoniflorin, a constituent of chinese paeony root.

1984 ◽  
Vol 32 (4) ◽  
pp. 1461-1466 ◽  
Author(s):  
MATAO KANAOKA ◽  
SABURO YANO ◽  
HIROMI KATO ◽  
KYOKO NAKANISHI ◽  
MASAO YOSHIZAKI
Keyword(s):  
Enzyme Immunoassay ◽  
Active Constituents ◽  
Medicinal Drugs

scholarly journals Studies on the enzyme immunoassay of bio-active constituents contained in oriental medicinal drugs. II. Enzyme immunoassay of glycyrrhizin.

1983 ◽  
Vol 31 (6) ◽  
pp. 1866-1873 ◽  
Author(s):  
MATAO KANAOKA ◽  
SABURO YANO ◽  
HIROMI KATO ◽  
NAOKO NAKANO ◽  
EIKO KINOSHITA
Keyword(s):  
Enzyme Immunoassay ◽  
Active Constituents ◽  
Medicinal Drugs

A novel enzyme immunoassay for the direct detection of H. pylori antigens in stool

2001 ◽  
Vol 120 (5) ◽  
pp. A492-A493 ◽  
Author(s):  
E HAINDL ◽  
H BENESCH ◽  
A FINCK ◽  
V MUEHISTEIN ◽  
A LEODOLTER ◽  
...  
Keyword(s):  
Enzyme Immunoassay ◽  
Direct Detection ◽  
H Pylori

Efficacy of enzyme immunoassay for the detection of helicobacter pylori antigens in frozen stool specimens: Local validation

2001 ◽  
Vol 120 (5) ◽  
pp. A492-A492
Author(s):  
Y YEE ◽  
E YIP ◽  
T QUE ◽  
K LI ◽  
C LEE ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Enzyme Immunoassay ◽  
Stool Specimens

A Monoclonal Antibody-Based Enzyme Immunoassay for Fibrin Degradation Products in Plasma

1988 ◽  
Vol 59 (02) ◽  
pp. 310-315 ◽  
Author(s):  
P W Koppert ◽  
E Hoegee-de Nobel ◽  
W Nieuwenhuizen
Keyword(s):  
Enzyme Immunoassay ◽  
Degradation Products ◽  
Blood Clot ◽  
Tissue Type ◽  
Fibrin Degradation Products ◽  
Type Plasminogen Activator ◽  
Strong Positive Reaction ◽  
Sandwich Type ◽  
Capture Antibody

SummaryWe have developed a sandwich-type enzyme immunoassay (EIA) for the quantitation of fibrin degradation products (FbDP) in plasma with a time-to-result of only 45 minutes.* The assay is based on the combination of the specificities of two monoclonal antibodies (FDP-14 and DD-13), developed in our institute. FDP-14, the capture antibody, binds both fibrinogen degradation products (FbgDP) and FbDP, but does not react with the parent fibrin(ogen) molecules. It has its epitope in the E-domain of the fibrinogen molecule on the Bβ-chain between amino acids 54-118. Antibody DD-13 was raised using D-dimer as antigen and is used as a tagging antibody, conjugated with horse-radish peroxidase. A strong positive reaction is obtained with a whole blood clot lysate (lysis induced by tissue-type plasminogen activator) which is used as a standard. The EIA does virtually not detect FbgDP i. e. purified fragments X, Y, or FbgDP generated in vitro in plasma by streptokinase treatment. This indicates that the assay is specific for fibrin degradation products.We have successfully applied this assay to the plasma of patients with a variety of diseased states. In combination with the assay previously developed by us for FbgDP and for the total amount of FbgDP + FbDP (TDP) in plasma, we are now able to study the composition of TDP in patients plasma in terms of FbgDP and FbDP.

Sign in / Sign up

Export Citation Format

Share Document